Form 4: Enfusion CEO Oleg Movchan Reports Stock Transactions

Oleg Movchan, CEO of Enfusion, Inc., reports acquisition and disposal of Class A Common Stock, including shares acquired through vested options and shares withheld for tax obligations.

Summary

• Oleg Movchan, CEO of Enfusion, Inc., filed a Form 4 detailing changes in beneficial ownership of Enfusion's Class A Common Stock.
• On March 1, 2024, Mr. Movchan acquired 13,887 shares of Class A Common Stock at a price of $8.67 per share through the Enfusion, Inc. 2021 Stock Option and Incentive Plan.
• On the same day, 4,069 shares were disposed of at $8.67 per share to satisfy tax withholding obligations.
• Following these transactions, Mr. Movchan directly owns 279,772 shares of Class A Common Stock.
• Additionally, Mr. Movchan may be deemed to have shared voting and dispositive power over 1,151,818 shares held by CSL Tech Holdings, LLC, where he is a co-manager, but he disclaims beneficial ownership except to the extent of his pecuniary interest.
• CSL Tech Holdings, LLC also filed a form 4 related to these transactions.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to stock options and tax obligations. There's no indication of unusual activity or concern.

Positives

• The acquisition of shares through vested options indicates confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and major shareholders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a relatively small number of shares compared to the total outstanding.

Key Dates